PROJECTS & INITIATIVES

Neural Networks or so called Artificial intelligence (AI) plays a significant role in predicting immune responses using Next-Generation Sequencing (NGS) data due to its ability to analyze complex biological datasets and recognize patterns that are not easily discernible by human experts. By utilizing AI in conjunction with NGS, researchers can gain deeper insights into the immune system and advance the personalized medicine , improving patient outcomes and treatment strategies.

This initiative is revolutionizing personalized health care with cutting-edge test panels for AI-powered analysis of blood, saliva, urine, and biome. By objectively quantifying the real biologic age of an individual, our technology through an App can provide customized recommendations for peptide therapies and other interventions aimed at prolonging life and improving quality of living. With a focus on precision medicine, we are leading the way in helping individuals optimize their health and well-being based on their unique "biological makeup". 

AIDS/HIV-related project. Solves the problem of the emergence of resistance of the virus to the medications taken, and also studies new strains of the virus. Implemented jointly by leading European institutions and scientists in the field. Within the framework of international programs, WHO participates in the fight against the AIDS epidemic in the countries of sub-equatorial Africa. 

Top team of European experts in virology is dedicated to developing cutting-edge anti-aging solution that target the root causes of aging in the body. We believe that there are peptides or other cells that trigger the aging process. This phenomenon could be controlled and even reversed. The efforts of R&D team are focused on finding the right treatment to prolong the life span of human and to enhance its quality of living.

This project is to promote organ transplantation and reduce the risk of rejection after surgery. Solves the problem of early diagnosis of the potential development of an immune system response and its attack on an organ or recipient organism. It allows you to save both the health of the patient and the organ itself.

This project in the field of predicting and preventing the development of side effects when taking anti-cancer drugs, which allows developing a more acceptable course of treatment for the patient. Implemented in collaboration with world-leading manufacturers of anti-cancer therapy.

Educated AI has the potential to significantly aid in the early prediction of prostate cancer, which is crucial for improving treatment outcomes and survival rates. By utilizing neural networks in this way, doctors can enhance their ability to detect the problem at its earliest before symptoms appear and thus at the most treatable stages, potentially saving lives and reducing the need for more invasive treatments.

Eisai and Biogen developed a medication called Leqembi to target one of the pathologies of Alzheimer's disease: accumulation of amyloid-beta plaques. The drug is designed to help clear these from the brain. Leqembi's role in the broader context of aging is primarily tied to its potential impact on one specific age-related condition. Our AI platform may speed up testing of this drug and study early immune response to it.

This project aims at R&D on extraction of animal cells that are capable of producing hormones identical to or suitable for replacing those of human bodies. Such advances give a second chance for people with their organs or cells damaged by accidents, virus or toxic impact as well as in a result of inherited deceases. This could help people with Diabetes, thyroid gland dysfunction and others.